Sihuan Pharmaceutical Co., Ltd. was reduced by two shareholders to cash out HK $1.8 billion
-
Last Update: 2013-09-10
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
On September 10, according to Hong Kong Ming Pao, market news revealed that two shareholders of Sihuan Pharmaceutical (00460 HK) allotted old shares to cash out yesterday Among them, the major shareholders allotted about 250 million old shares, while the other shareholder, Morgan Stanley, reduced about 100 million shares The allotment price was 3.5% to 6.8% off yesterday's closing price, resulting in a total cash out of about 1.875 billion yuan by two shareholders Sihuan pharmaceutical was listed in Singapore, then privatized and listed in Hong Kong in 2010 Before listing, Sihuan had planned to introduce new Tianyu capital of private fund as pre listing investor New Tianyu capital plans to buy 9% equity of Sihuan pharmaceutical with us $80 million However, in the end, the relevant shares were rejected by the Listing Committee of the Hong Kong stock exchange, which means that the time between the shares and the implementation of listing is too short, in violation of relevant regulations The fourth ring road finally listed at yuan per share Although it rose by 30% on the first day of listing, it fell back again and again Last year, it saw yuan at the bottom of the year, and its market value evaporated by 50% compared with that when it was listed Until May of this year, its share price saw its hometown again In the near future, it saw yuan at the top because of its mid-term performance.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
